{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T21:53:10Z","timestamp":1784238790909,"version":"3.55.0"},"posted":{"date-parts":[[2023,8,1]]},"group-title":"In Review","reference-count":48,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,6,14]]},"abstract":"<title>Abstract<\/title>\n        <p>Purpose\n Inborn errors of the IL-17A\/F-responsive pathway lead to chronic mucocutaneous candidiasis (CMC) as a predominant clinical phenotype, without other significant clinical manifestations apart from mucocutaneous staphylococcal diseases. Amongst inborn errors affecting IL-17-dependent immunity, autosomal recessive (AR) IL-17RC deficiency is a rare disease with only three kindreds described to date. The lack of an <italic>in vitro<\/italic> functional evaluation system of <italic>IL17RC<\/italic> variants renders its diagnosis difficult. We sought to characterize a seven-year-old Japanese girl with CMC carrying a novel homozygous duplication variant of <italic>IL17RC<\/italic> and establish a simple <italic>in vitro<\/italic> system to evaluate the impact of this variant.\nMethods\n Flow cytometry, qPCR, RNA-sequencing, and immunoblotting were conducted, and an <italic>IL17RC<\/italic>-knockout cell line was established for functional evaluation.\nResults\n The patient presented with oral and mucocutaneous candidiasis without staphylococcal diseases since the age of three months. Genetic analysis showed that the novel duplication variant (Chr3: 9,971,476-9,971,606 dup (+\u2009131bp)) involving exon 13 of <italic>IL17RC<\/italic> results in a premature stop codon (p.D457Afs*16 or p.D457Afs*17). Our functional evaluation system revealed this duplication to be loss-of-function and enabled discrimination between loss-of-function and neutral <italic>IL17RC<\/italic> variants. The lack of response to IL-17A by the patient\u2019s SV40-immortalized fibroblasts was restored by introducing WT-<italic>IL17RC<\/italic>, suggesting that the genotype identified is responsible for her clinical phenotype.\nConclusions\n The clinical and cellular phenotype of the current case of AR IL-17RC deficiency supports a previous report on this rare disorder. Our newly established evaluation system will be useful for diagnosis of AR IL-17RC deficiency, providing accurate validation of unknown <italic>IL17RC<\/italic> variants.<\/p>","DOI":"10.21203\/rs.3.rs-3062583\/v1","type":"posted-content","created":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T14:13:14Z","timestamp":1690899194000},"source":"Crossref","is-referenced-by-count":2,"title":["Isolated chronic mucocutaneous candidiasis\u00a0due to a novel duplication variant of IL17RC"],"prefix":"10.21203","author":[{"given":"Kosuke","family":"Noma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyuki","family":"Tsumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaki","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiaki","family":"Sakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moe","family":"Tamaura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Imanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Mizoguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Karakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichi","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayo","family":"Shoji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Hosokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazushi","family":"Izawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Laurent","family":"Casanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Puel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart G","family":"Tangye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy S","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Ohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4622-5657","authenticated-orcid":false,"given":"Satoshi","family":"Okada","sequence":"additional","affiliation":[{"name":"Hiroshima University Graduate School of Biomedical and Health Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"2","key":"ref1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/00006454-200102000-00017","article-title":"Chronic mucocutaneous candidiasis. Pediatr Infect Dis","volume":"20","author":"Kirkpatrick CH","unstructured":"Kirkpatrick CH, Hill HR. Chronic mucocutaneous candidiasis. Pediatr Infect Dis J. 2001 Feb;20(2):197\u2013206. DOI:https:\/\/doi.org\/10.1097\/00006454-200102000-00017."},{"issue":"6","key":"ref2","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1097\/ACI.0b013e328358cc0b","article-title":"Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis","volume":"12","author":"Puel A","unstructured":"Puel A, Cypowyj S, Mar\u00f3di L, Abel L, Picard C, Casanova JL. Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis. Curr Opin Allergy Clin Immunol. 2012 Dec;12(6):616\u201322. https:\/\/doi.org\/10.1097\/ACI.0b013e328358cc0b.","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"4","key":"ref3","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.coi.2010.06.009","article-title":"Inborn errors of mucocutaneous immunity to Candida albicans in humans: a role for IL-17 cytokines? Curr Opin Immunol","volume":"22","author":"Puel A","unstructured":"Puel A, Picard C, Cypowyj S, Lilic D, Abel L, Casanova JL. Inborn errors of mucocutaneous immunity to Candida albicans in humans: a role for IL-17 cytokines? Curr Opin Immunol. 2010 Aug;22(4):467\u201374. DOI:https:\/\/doi.org\/10.1016\/j.coi.2010.06.009."},{"issue":"6\u20137","key":"ref4","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s00439-020-02141-7","article-title":"Human inborn errors of immunity underlying superficial or invasive candidiasis","volume":"139","author":"Puel A","unstructured":"Puel A. Human inborn errors of immunity underlying superficial or invasive candidiasis. Hum Genet. 2020 Jun;139(6\u20137):1011\u201322. https:\/\/doi.org\/10.1007\/s00439-020-02141-7.","journal-title":"Hum Genet"},{"issue":"12","key":"ref5","doi-asserted-by":"publisher","first-page":"e114","DOI":"10.1038\/cti.2016.71","article-title":"Chronic mucocutaneous candidiasis disease associated with inborn errors of IL-17 immunity","volume":"5","author":"Okada S","unstructured":"Okada S, Puel A, Casanova JL, Kobayashi M. Chronic mucocutaneous candidiasis disease associated with inborn errors of IL-17 immunity. Clin Transl Immunol. 2016 Dec;5(12):e114. https:\/\/doi.org\/10.1038\/cti.2016.71.","journal-title":"Clin Transl Immunol"},{"issue":"7","key":"ref6","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1084\/jem.20080321","article-title":"Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells","volume":"205","author":"Beaucoudtey L","year":"2008","unstructured":"De Beaucoudtey L, Puel A, Filipe-Santos O, Cobat A, Ghandil P, Chrabieh M, et al. Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J Exp Med. 2008;205(7):1543\u201350. https:\/\/doi.org\/10.1084\/jem.20080321.","journal-title":"J Exp Med"},{"issue":"7","key":"ref7","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1084\/jem.20080218","article-title":"Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3","volume":"205","author":"Ma CS","year":"2008","unstructured":"Ma CS, Chew GYJ, Simpson N, Priyadarshi A, Wong M, Grimbacher B, et al. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J Exp Med. 2008;205(7):1551\u20137. https:\/\/doi.org\/10.1084\/jem.20080218.","journal-title":"J Exp Med"},{"issue":"7188","key":"ref8","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/nature06764","article-title":"Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome","volume":"452","author":"Milner JD","year":"2008","unstructured":"Milner JD, Brenchley JM, Laurence A, Freeman AF, Hill BJ, Elias KM, et al. Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature. 2008;452(7188):773\u20136. https:\/\/doi.org\/10.1038\/nature06764.","journal-title":"Nature"},{"issue":"4","key":"ref9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MD.0b013e31825f95b9","article-title":"Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: Molecular, cellular, and clinical features from a french national survey","volume":"91","author":"Chandesris MO","year":"2012","unstructured":"Chandesris MO, Melki I, Natividad A, Puel A, Fieschi C, Yun L, et al. Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: Molecular, cellular, and clinical features from a french national survey. Med (United States). 2012;91(4):1\u201319. https:\/\/doi.org\/10.1097\/MD.0b013e31825f95b9.","journal-title":"Med (United States)"},{"issue":"6","key":"ref10","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191804","article-title":"Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome","volume":"217","author":"B\u00e9ziat V","year":"2020","unstructured":"B\u00e9ziat V, Tavernier SJ, Chen YH, Ma CS, Materna M, Laurence A, et al. Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome. J Exp Med. 2020;217(6). https:\/\/doi.org\/10.1084\/jem.20191804.","journal-title":"J Exp Med"},{"issue":"24","key":"ref11","doi-asserted-by":"publisher","DOI":"10.1126\/SCIIMMUNOL.AAT4956","article-title":"A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity","volume":"3","author":"B\u00e9ziat V","year":"2018","unstructured":"B\u00e9ziat V, Li J, Lin JX, Ma CS, Li P, Bousfiha A, et al. A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity. Sci Immunol. 2018;3(24). https:\/\/doi.org\/10.1126\/SCIIMMUNOL.AAT4956.","journal-title":"Sci Immunol"},{"issue":"24","key":"ref12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/sciimmunol.aat4941","article-title":"ZNF341 controls STAT3 expression and thereby immunocompetence","volume":"15","author":"Frey-Jakobs S","unstructured":"Frey-Jakobs S, Hartberger JM, Fliegauf M, Bossen C, Wehmeyer ML, Neubauer JC et al. ZNF341 controls STAT3 expression and thereby immunocompetence. Sci Immunol 2018 Jun 15;3(24):1\u20137. DOI:https:\/\/doi.org\/10.1126\/sciimmunol.aat4941.","journal-title":"Sci Immunol 2018 Jun"},{"issue":"8","key":"ref13","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s10875-020-00847-x","article-title":"Human STAT1 Gain-of-Function Heterozygous Mutations: Chronic Mucocutaneous Candidiasis and Type I Interferonopathy","volume":"40","author":"Okada S","year":"2020","unstructured":"Okada S, Asano T, Moriya K, Boisson-Dupuis S, Kobayashi M, Casanova JL, et al. Human STAT1 Gain-of-Function Heterozygous Mutations: Chronic Mucocutaneous Candidiasis and Type I Interferonopathy. J Clin Immunol. 2020;40(8):1065\u201381. https:\/\/doi.org\/10.1007\/s10875-020-00847-x.","journal-title":"J Clin Immunol"},{"issue":"18","key":"ref14","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1084\/jem.20110958","article-title":"Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis","volume":"208","author":"Liu L","year":"2011","unstructured":"Liu L, Okada S, Kong XF, Kreins AY, Cypowyj S, Abhyankar A, et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med. 2011;208(18):1635\u201348. https:\/\/doi.org\/10.1084\/jem.20110958.","journal-title":"J Exp Med"},{"issue":"1","key":"ref15","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10875-015-0214-9","article-title":"The Extended Clinical Phenotype of 26 Patients with Chronic Mucocutaneous Candidiasis due to Gain-of-Function Mutations in STAT1","volume":"36","author":"Depner M","year":"2016","unstructured":"Depner M, Fuchs S, Raabe J, Frede N, Glocker C, Doffinger R, et al. The Extended Clinical Phenotype of 26 Patients with Chronic Mucocutaneous Candidiasis due to Gain-of-Function Mutations in STAT1. J Clin Immunol. 2016;36(1):73\u201384. https:\/\/doi.org\/10.1007\/s10875-015-0214-9.","journal-title":"J Clin Immunol"},{"issue":"25","key":"ref16","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1182\/blood-2015-11-679902","article-title":"Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype","volume":"127","author":"Toubiana J","year":"2016","unstructured":"Toubiana J, Okada S, Hiller J, Oleastro M, Gomez ML, Becerra JCA, et al. Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype. Blood. 2016;127(25):3154\u201364. https:\/\/doi.org\/10.1182\/blood-2015-11-679902.","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.coi.2021.02.009","article-title":"Inborn errors of STAT1 immunity","volume":"72","author":"Mizoguchi Y","year":"2021","unstructured":"Mizoguchi Y, Okada S. Inborn errors of STAT1 immunity. Curr Opin Immunol. 2021;72:59\u201364. DOI:https:\/\/doi.org\/10.1016\/j.coi.2021.02.009.","journal-title":"Curr Opin Immunol"},{"issue":"41","key":"ref18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1126\/sciimmunol.aax7965","article-title":"Chronic mucocutaneous candidiasis and connective tissue disorder in humans with impaired JNK1-dependent responses to IL-17A\/F and TGF-\u03b2","volume":"4","author":"Li J","year":"2019","unstructured":"Li J, Ritelli M, Ma CS, Rao G, Habib T, Corvilain E, et al. Chronic mucocutaneous candidiasis and connective tissue disorder in humans with impaired JNK1-dependent responses to IL-17A\/F and TGF-\u03b2. Sci Immunol. 2019;4(41):139\u201348. https:\/\/doi.org\/10.1126\/sciimmunol.aax7965.","journal-title":"Sci Immunol"},{"issue":"6","key":"ref19","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/MD.0b013e3181fdd832","article-title":"Revisiting human IL-12R\u03b21 deficiency: A survey of 141 patients from 30 countries","volume":"89","author":"Beaucoudrey L","year":"2010","unstructured":"De Beaucoudrey L, Samarina A, Bustamante J, Cobat A, Boisson-Dupuis S, Feinberg J, et al. Revisiting human IL-12R\u03b21 deficiency: A survey of 141 patients from 30 countries. Med (Baltim). 2010;89(6):381\u2013402. https:\/\/doi.org\/10.1097\/MD.0b013e3181fdd832.","journal-title":"Med (Baltim)"},{"issue":"80","key":"ref20","doi-asserted-by":"publisher","first-page":"eabq5204","DOI":"10.1126\/sciimmunol.abq5204","article-title":"Human IL-23 is essential for IFN-\u03b3-dependent immunity to mycobacteria","volume":"8","author":"Philippot Q","year":"2023","unstructured":"Philippot Q, Ogishi M, Bohlen J, Puchan J, Arias AA, Nguyen T, et al. Human IL-23 is essential for IFN-\u03b3-dependent immunity to mycobacteria. Sci Immunol [Internet]. 2023;8(80):eabq5204. https:\/\/doi.org\/10.1126\/sciimmunol.abq5204. Feb 17 [cited 2023 Feb 16];.","journal-title":"Sci Immunol [Internet]"},{"issue":"2","key":"ref21","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/cid\/cit722","article-title":"Clinical features of candidiasis in patients with inherited interleukin 12 receptor \u03b21 deficiency","volume":"58","author":"Ouederni M","year":"2014","unstructured":"Ouederni M, Sanal O, Ikincio\u01e7ullari A, Tezcan I, Dogu F, Sologuren I, et al. Clinical features of candidiasis in patients with inherited interleukin 12 receptor \u03b21 deficiency. Clin Infect Dis. 2014;58(2):204\u201313. https:\/\/doi.org\/10.1093\/cid\/cit722.","journal-title":"Clin Infect Dis"},{"issue":"18","key":"ref22","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1056\/nejmoa0810719","article-title":"A Homozygous CARD9 Mutation in a Family with Susceptibility to Fungal Infections","volume":"361","author":"Glocker EO","year":"2009","unstructured":"Glocker EO, Hennigs A, Nabavi M, Sch\u00e4ffer AA, Woellner C, Salzer U, et al. A Homozygous CARD9 Mutation in a Family with Susceptibility to Fungal Infections. N Engl J Med. 2009;361(18):1727\u201335. https:\/\/doi.org\/10.1056\/nejmoa0810719.","journal-title":"N Engl J Med"},{"issue":"18","key":"ref23","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1056\/NEJMoa1208487","article-title":"Deep dermatophytosis and inherited CARD9 deficiency","volume":"31","author":"Lanternier F","unstructured":"Lanternier F, Pathan S, Vincent QB, Liu L, Cypowyj S, Prando C, et al. Deep dermatophytosis and inherited CARD9 deficiency. N Engl J Med. 2013 Oct;31(18):1704\u201314. https:\/\/doi.org\/10.1056\/NEJMoa1208487.","journal-title":"N Engl J Med"},{"issue":"6","key":"ref24","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1007\/s10875-018-0539-2","article-title":"Inherited CARD9 Deficiency: Invasive Disease Caused by Ascomycete Fungi in Previously Healthy Children and Adults","volume":"38","author":"Corvilain E","unstructured":"Corvilain E, Casanova JL, Puel A. Inherited CARD9 Deficiency: Invasive Disease Caused by Ascomycete Fungi in Previously Healthy Children and Adults. J Clin Immunol. 2018 Aug;38(6):656\u201393. https:\/\/doi.org\/10.1007\/s10875-018-0539-2.","journal-title":"J Clin Immunol"},{"key":"ref25","doi-asserted-by":"publisher","author":"Okada S","unstructured":"Okada S, Markle JG, Deenick EK, Mele F, Averbuch D, Lagos M et al. IMMUNODEFICIENCIES. Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations. Science. 2015 Aug 7;349(6248):606\u201313. DOI:https:\/\/doi.org\/10.1126\/science.aaa4282.","DOI":"10.1126\/science.aaa4282"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/J.MIB.2017.10.016","article-title":"Inborn errors of immunity underlying fungal diseases in otherwise healthy individuals","volume":"1","author":"Li J","unstructured":"Li J, Vinh DC, Casanova JL, Puel A. Inborn errors of immunity underlying fungal diseases in otherwise healthy individuals. Curr Opin Microbiol 2017 Dec 1;40:46\u201357. DOI:https:\/\/doi.org\/10.1016\/J.MIB.2017.10.016.","journal-title":"Curr Opin Microbiol 2017 Dec"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1126\/science.1200439","author":"Puel A","year":"2011","unstructured":"Puel A, Cypowyj S, Bustamante J, Wright JF, Liu L, Lim HK et al. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science. 2011 Apr 1;332(6025):65\u20138. DOI:https:\/\/doi.org\/10.1126\/science.1200439."},{"issue":"4","key":"ref28","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.immuni.2013.09.002","article-title":"An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis","volume":"39","author":"Boisson B","year":"2013","unstructured":"Boisson B, Wang C, Pedergnana V, Wu L, Cypowyj S, Rybojad M, et al. An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis. Immunity. 2013;39(4):676\u201386. https:\/\/doi.org\/10.1016\/j.immuni.2013.09.002.","journal-title":"Immunity"},{"issue":"51","key":"ref29","doi-asserted-by":"publisher","first-page":"E8277","DOI":"10.1073\/pnas.1618300114","article-title":"Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency","volume":"113","author":"L\u00e9vy R","year":"2016","unstructured":"L\u00e9vy R, Okada S, B\u00e9ziat V, Moriya K, Liu C, Chai LYA, et al. Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency. Proc Natl Acad Sci U S A. 2016;113(51):E8277\u201385. https:\/\/doi.org\/10.1073\/pnas.1618300114.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"ref30","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1084\/jem.20141065","article-title":"Inherited IL-17RC deficiency in patients with chronic mucocutaneous candidiasis","volume":"212","author":"Ling Y","year":"2015","unstructured":"Ling Y, Cypowyj S, Aytekin C, Galicchio M, Camcioglu Y, Nepesov S, et al. Inherited IL-17RC deficiency in patients with chronic mucocutaneous candidiasis. J Exp Med. 2015;212(5):619\u201331. https:\/\/doi.org\/10.1084\/jem.20141065.","journal-title":"J Exp Med"},{"issue":"6","key":"ref31","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1007\/s10875-021-01026-2","article-title":"A Novel TRAF3IP2 Mutation Causing Chronic Mucocutaneous Candidiasis","volume":"41","author":"Marujo F","year":"2021","unstructured":"Marujo F, Pelham SJ, Freixo J, Cordeiro AI, Martins C, Casanova JL, et al. A Novel TRAF3IP2 Mutation Causing Chronic Mucocutaneous Candidiasis. J Clin Immunol. 2021;41(6):1376\u20139. https:\/\/doi.org\/10.1007\/s10875-021-01026-2.","journal-title":"J Clin Immunol"},{"issue":"1","key":"ref32","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.jaci.2020.12.629","article-title":"Two patients with chronic mucocutaneous candidiasis caused by TRAF3IP2 deficiency","volume":"148","author":"Shafer S","unstructured":"Shafer S, Yao Y, Comrie W, Cook S, Zhang Y, Yesil G, et al. Two patients with chronic mucocutaneous candidiasis caused by TRAF3IP2 deficiency. J Allergy Clin Immunol. 2021 Jul;148(1):256\u2013261e2. https:\/\/doi.org\/10.1016\/j.jaci.2020.12.629.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"ref33","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1007\/s10875-019-00664-x","article-title":"Chronic Mucocutaneous Candidiasis in an Adolescent Boy Due to a Novel Mutation in TRAF3IP2","volume":"39","author":"Bhattad S","year":"2019","unstructured":"Bhattad S, Dinakar C, Pinnamaraju H, Ganapathy A, Mannan A. Chronic Mucocutaneous Candidiasis in an Adolescent Boy Due to a Novel Mutation in TRAF3IP2. J Clin Immunol. 2019;39(6):596\u20139. https:\/\/doi.org\/10.1007\/s10875-019-00664-x.","journal-title":"J Clin Immunol"},{"issue":"3","key":"ref34","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/mi.2017.97","article-title":"IL-17 immunity in mice and humans: Host defense vs. excessive inflammation","volume":"11","author":"Li J","year":"2018","unstructured":"Li J, Casanova JL, Puel A, Mucocutaneous. IL-17 immunity in mice and humans: Host defense vs. excessive inflammation. Mucosal Immunol. 2018;11(3):581\u20139. https:\/\/doi.org\/10.1038\/mi.2017.97.","journal-title":"Mucosal Immunol"},{"issue":"8","key":"ref35","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/nri2586","article-title":"Structure and signalling in the IL-17 receptor family","volume":"9","author":"Gaffen SL","year":"2009","unstructured":"Gaffen SL. Structure and signalling in the IL-17 receptor family. Nat Rev Immunol. 2009;9(8):556\u201367. https:\/\/doi.org\/10.1038\/nri2586.","journal-title":"Nat Rev Immunol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1038\/s41590-019-0514-y","article-title":"IL-17 receptor\u2013based signaling and implications for disease","volume":"20","author":"Li X","year":"2019","unstructured":"Li X, Bechara R, Zhao J, McGeachy MJ, Gaffen SL. IL-17 receptor\u2013based signaling and implications for disease. Nat Immunol. 2019;20:1594\u2013602. https:\/\/doi.org\/10.1038\/s41590-019-0514-y.","journal-title":"Nat Immunol"},{"issue":"6","key":"ref37","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.celrep.2019.01.041","article-title":"RNA-Seq Signatures Normalized by mRNA Abundance Allow Absolute Deconvolution of Human Immune Cell Types","volume":"26","author":"Monaco G","year":"2019","unstructured":"Monaco G, Lee B, Xu W, Mustafah S, Hwang YY, Carr\u00e9 C, et al. RNA-Seq Signatures Normalized by mRNA Abundance Allow Absolute Deconvolution of Human Immune Cell Types. Cell Rep. 2019;26(6):1627\u20131640e7. https:\/\/doi.org\/10.1016\/j.celrep.2019.01.041.","journal-title":"Cell Rep"},{"issue":"2","key":"ref38","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.immuni.2011.02.012","article-title":"Functional Specialization of Interleukin-17 Family Members","volume":"34","author":"Iwakura Y","year":"2011","unstructured":"Iwakura Y, Ishigame H, Saijo S, Nakae S. Functional Specialization of Interleukin-17 Family Members. Immunity. 2011;34(2):149\u201362. https:\/\/doi.org\/10.1016\/j.immuni.2011.02.012.","journal-title":"Immunity"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2018.04.004","author":"Fujiki R","year":"2018","unstructured":"Fujiki R, Ikeda M, Yoshida A, Akiko M, Yao Y, Nishimura M et al. Assessing the Accuracy of Variant Detection in Cost-Effective Gene Panel Testing by Next-Generation Sequencing. J Mol Diagn. 2018 Sep 1;20(5):572\u201382. DOI:https:\/\/doi.org\/10.1016\/j.jmoldx.2018.04.004."},{"key":"ref40","doi-asserted-by":"publisher","author":"Naito Y","unstructured":"Naito Y, Hino K, Bono H, Ui-Tei K. CRISPRdirect: software for designing CRISPR\/Cas guide RNA with reduced off-target sites. Bioinformatics. 2015 Apr 1;31(7):1120\u20133. DOI:https:\/\/doi.org\/10.1093\/BIOINFORMATICS\/BTU743.","DOI":"10.1093\/BIOINFORMATICS\/BTU743"},{"issue":"11","key":"ref41","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Ran FA","unstructured":"Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F. Genome engineering using the CRISPR-Cas9 system. Nat Protoc. 2013 Nov;8(11):2281\u2013308. https:\/\/doi.org\/10.1038\/nprot.2013.143.","journal-title":"Nat Protoc"},{"issue":"2","key":"ref42","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.4049\/jimmunol.0903739","article-title":"IL-17RC is required for immune signaling via an extended SEF\/IL-17R signaling domain in the cytoplasmic tail","volume":"15","author":"Ho AW","unstructured":"Ho AW, Shen F, Conti HR, Patel N, Childs EE, Peterson AC et al. IL-17RC is required for immune signaling via an extended SEF\/IL-17R signaling domain in the cytoplasmic tail. J Immunol 2010 Jul 15;185(2):1063\u201370. DOI:https:\/\/doi.org\/10.4049\/jimmunol.0903739.","journal-title":"J Immunol 2010 Jul"},{"issue":"2","key":"ref43","doi-asserted-by":"publisher","first-page":"68","DOI":"10.14785\/lymphosign-2019-0007","article-title":"Chronic mucocutaneous candidiasis associated with a novel frameshift mutation in IL-17 receptor alpha","volume":"6","author":"Aujnarain A","year":"2019","unstructured":"Aujnarain A, Dadi H, Mandola A. Chronic mucocutaneous candidiasis associated with a novel frameshift mutation in IL-17 receptor alpha. LymphoSign J. 2019;6(2):68\u201374. https:\/\/doi.org\/10.14785\/lymphosign-2019-0007.","journal-title":"LymphoSign J"},{"issue":"8","key":"ref44","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1007\/s10875-021-01086-4","article-title":"Genetic Analysis of a Cohort of 275 Patients with Hyper-IgE Syndromes and\/or Chronic Mucocutaneous Candidiasis","volume":"41","author":"Frede N","unstructured":"Frede N, Rojas-Restrepo J, Caballero Garcia de Oteyza A, Buchta M, H\u00fcbscher K, G\u00e1mez-D\u00edaz L et al. Genetic Analysis of a Cohort of 275 Patients with Hyper-IgE Syndromes and\/or Chronic Mucocutaneous Candidiasis. J Clin Immunol 2021 Nov;41(8):1804\u201338. DOI:https:\/\/doi.org\/10.1007\/s10875-021-01086-4.","journal-title":"J Clin Immunol 2021"},{"issue":"1","key":"ref45","doi-asserted-by":"publisher","first-page":"135","DOI":"10.24953\/turkjped.2022.40","article-title":"A family with interleukin-17 receptor A deficiency: a case report and review of the literature","volume":"65","author":"K\u0131l\u0131\u00e7 M","year":"2023","unstructured":"K\u0131l\u0131\u00e7 M, \u00d6zcan MH, Ta\u015fk\u0131n E, \u015een A. A family with interleukin-17 receptor A deficiency: a case report and review of the literature. Turk J Pediatr. 2023;65(1):135\u201343. DOI:https:\/\/doi.org\/10.24953\/turkjped.2022.40.","journal-title":"Turk J Pediatr"},{"issue":"3","key":"ref46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1073\/pnas.2001248118","article-title":"Negative selection on human genes underlying inborn errors depends on disease outcome and both the mode and mechanism of inheritance","volume":"118","author":"Rapaport F","year":"2021","unstructured":"Rapaport F, Boisson B, Gregor A, B\u00e9ziat V, Boisson-Dupuis S, Bustamante J, et al. Negative selection on human genes underlying inborn errors depends on disease outcome and both the mode and mechanism of inheritance. Proc Natl Acad Sci U S A. 2021;118(3):1\u20139. https:\/\/doi.org\/10.1073\/pnas.2001248118.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"44","key":"ref47","doi-asserted-by":"publisher","first-page":"13615","DOI":"10.1073\/pnas.1518646112","article-title":"The human gene damage index as a gene-level approach to prioritizing exome variants","volume":"112","author":"Itan Y","year":"2015","unstructured":"Itan Y, Shang L, Boisson B, Patin E, Bolze A, Moncada-V\u00e9lez M, et al. The human gene damage index as a gene-level approach to prioritizing exome variants. Proc Natl Acad Sci U S A. 2015;112(44):13615\u201320. https:\/\/doi.org\/10.1073\/pnas.1518646112.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"36","key":"ref48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/sciimmunol.aau9657","article-title":"Interleukin-17 receptor D constitutes an alternative receptor for interleukin-17A important in psoriasis-like skin inflammation","volume":"4","author":"Su Y","year":"2019","unstructured":"Su Y, Huang J, Zhao X, Lu H, Wang W, Yang XO, et al. Interleukin-17 receptor D constitutes an alternative receptor for interleukin-17A important in psoriasis-like skin inflammation. Sci Immunol. 2019;4(36):1\u201316. https:\/\/doi.org\/10.1126\/sciimmunol.aau9657.","journal-title":"Sci Immunol"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3062583\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3062583\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,25]],"date-time":"2023-12-25T15:05:54Z","timestamp":1703516754000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3062583\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,1]]},"references-count":48,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-3062583\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1007\/s10875-023-01601-9","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2023,8,1]]},"subtype":"preprint"}}